These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 23116794)

  • 1. Influenza A(H1N1)pdm09: beyond the pandemic.
    Viasus D; Antón A; Pumarola T; Carratalà J
    Enferm Infecc Microbiol Clin; 2012 Oct; 30 Suppl 4():54-7. PubMed ID: 23116794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral treatment and vaccination for influenza A(H1N1)pdm09 virus: lessons learned from the pandemic.
    López-Medrano F; Fariñas MC; Payeras A; Pachón J
    Enferm Infecc Microbiol Clin; 2012 Oct; 30 Suppl 4():49-53. PubMed ID: 23116793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pandemic influenza A (H1N1) 2009 vaccine: an update.
    Goel MK; Goel M; Khanna P; Mittal K
    Indian J Med Microbiol; 2011; 29(1):13-8. PubMed ID: 21304188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pandemic novel 2009 H1N1 influenza: what have we learned?
    LaRussa P
    Semin Respir Crit Care Med; 2011 Aug; 32(4):393-9. PubMed ID: 21858744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
    Bateman AC; Kieke BA; Irving SA; Meece JK; Shay DK; Belongia EA
    J Infect Dis; 2013 Apr; 207(8):1262-9. PubMed ID: 23341536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pandemic (H1N1) 2009 influenza in hospitalized children in Manitoba: nosocomial transmission and lessons learned from the first wave.
    Fanella ST; Pinto MA; Bridger NA; Bullard JM; Coombs JM; Crockett ME; Olekson KL; Poliquin PG; Van Caeseele PG; Embree JE
    Infect Control Hosp Epidemiol; 2011 May; 32(5):435-43. PubMed ID: 21515973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degree of adherence to recommended antiviral treatment during the pandemic and post-pandemic periods of influenza A(H1N1)pdm09 in 148 intensive care units in Spain.
    Canadell L; Martín-Loeches I; Díaz E; Trefler S; Grau S; Yebenes JC; Almirall J; Olona M; Sureda F; Blanquer J; Rodriguez A;
    Med Intensiva; 2015 May; 39(4):222-33. PubMed ID: 25107582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany.
    Cramer J; Mac T; Hogan B; Stauga S; Eberhardt S; Wichmann O; Mertens T; Burchard G
    Euro Surveill; 2012 Jan; 17(2):. PubMed ID: 22264864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
    Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
    J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and epidemiological analysis of pandemic and post-pandemic influenza A(H1N1)pdm09 virus from central India.
    Sahu M; Singh N; Shukla MK; Potdar VA; Sharma RK; Sahare LK; Ukey MJ; Barde PV
    J Med Virol; 2018 Mar; 90(3):447-455. PubMed ID: 29073730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
    Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
    Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients.
    Reid G; Huprikar S; Patel G; Razonable RR; Mossad S; Levi M; Gregg K; Shoham S; Humar A; Adams W; Kumar D
    Transpl Infect Dis; 2013 Oct; 15(5):487-92. PubMed ID: 23890293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
    Renaud C; Kuypers J; Englund JA
    J Clin Virol; 2011 Oct; 52(2):70-8. PubMed ID: 21684202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic.
    Goldfarb I; Panda B; Wylie B; Riley L
    Am J Obstet Gynecol; 2011 Jun; 204(6 Suppl 1):S112-5. PubMed ID: 21345408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
    Hurt AC; Deng YM; Ernest J; Caldwell N; Leang L; Iannello P; Komadina N; Shaw R; Smith D; Dwyer DE; Tramontana AR; Lin RT; Freeman K; Kelso A; Barr IG
    Euro Surveill; 2011 Jan; 16(3):. PubMed ID: 21262183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.
    Ledesma J; Vicente D; Pozo F; Cilla G; Castro SP; Fernández JS; Ruiz MP; Navarro JM; Galán JC; Fernández M; Reina J; Larrauri A; Cuevas MT; Casas I; Breña PP;
    J Clin Virol; 2011 Jul; 51(3):205-8. PubMed ID: 21592854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemophagocytic lymphohistiocytosis associated with 2009 pandemic influenza A (H1N1) virus infection.
    Ozdemir H; Çiftçi E; Ince EU; Ertem M; Ince E; Doğru U
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):135-7. PubMed ID: 21285906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical effectiveness of oseltamivir in mild cases of pandemic influenza A H1N1 2009 infection.
    Lee JS; Park SY; Kim JS; You JY; Ju YS; Eom JS
    Scand J Infect Dis; 2012 Aug; 44(8):595-9. PubMed ID: 22497285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of antiviral agents for the management of severe influenza.
    Smith JR; Ariano RE; Toovey S
    Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pandemic vaccination strategies and influenza severe outcomes during the influenza A(H1N1)pdm09 pandemic and the post-pandemic influenza season: the Nordic experience.
    Gil Cuesta J; Aavitsland P; Englund H; Gudlaugsson Ó; Hauge SH; Lyytikäinen O; Sigmundsdóttir G; Tegnell A; Virtanen M; ; Krause TG
    Euro Surveill; 2016 Apr; 21(16):. PubMed ID: 27123691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.